These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3983039)

  • 41. [Estrogen antagonists and inhibitors in hormone therapy of breast cancer].
    Dryzhak VI
    Vopr Onkol; 1989; 35(7):771-8. PubMed ID: 2528239
    [No Abstract]   [Full Text] [Related]  

  • 42. [Oncological management of patients with metastatic breast cancer].
    Perey L; Leyvraz S
    Rev Med Suisse Romande; 1994 Sep; 114(9):793-8. PubMed ID: 7524127
    [No Abstract]   [Full Text] [Related]  

  • 43. [Chemotherapy of primary and metastasizing breast cancer].
    Hofmann V; Martz G
    Gynakol Rundsch; 1984; 24 Suppl 1():78-86. PubMed ID: 6394442
    [No Abstract]   [Full Text] [Related]  

  • 44. Tamoxifen treatment for breast cancer: concept to gold standard.
    Jordan VC
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):7-13. PubMed ID: 9065921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of anti-oestrogen Zitazonium (tamoxifen) as adjuvant to cytostatic treatment in metastatic breast cancer.
    Palka I; Jávor J
    Ther Hung; 1986; 34(4):217-23. PubMed ID: 3449976
    [No Abstract]   [Full Text] [Related]  

  • 46. [10 years' therapy of breast cancer].
    Schreml W
    Onkologie; 1986 Oct; 9 Suppl 2():49-56. PubMed ID: 3534674
    [No Abstract]   [Full Text] [Related]  

  • 47. Neoadjuvant chemotherapy in the conservative management of breast cancers: study of 143 patients.
    Jacquillat CI; Weil M; Auclerc G; Sellami M; Auclerc MF; Khayat D; Baillet F
    Recent Results Cancer Res; 1986; 103():113-9. PubMed ID: 3526473
    [No Abstract]   [Full Text] [Related]  

  • 48. [Adjuvant therapy of breast carcinoma].
    Kaufmann M
    Dtsch Med Wochenschr; 1994 Mar; 119(11):387-91. PubMed ID: 8131718
    [No Abstract]   [Full Text] [Related]  

  • 49. Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.
    Rose C; Kamby C; Mouridsen HT; Bastholt L; Brincker H; Skovgaard-Poulsen H; Andersen AP; Loft H; Dombernowsky P; Andersen KW
    Breast Cancer Res Treat; 1986; 7 Suppl():S45-50. PubMed ID: 3527306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer.
    Ravdin P
    Lancet; 2002 Jun; 359(9324):2126-7. PubMed ID: 12090973
    [No Abstract]   [Full Text] [Related]  

  • 51. Identification of patients with hormone receptor-positive breast cancer who need adjuvant tamoxifen therapy for more than 5 years.
    Wu CE; Chen SC; Chang HK; Lo YF; Hsueh S; Lin YC
    J Formos Med Assoc; 2016 Apr; 115(4):249-56. PubMed ID: 25900861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent advance in adjuvant therapy for breast cancer].
    Shimizu C; Watanabe T
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of primary cancer of the breast in elderly women. Role of hormone therapy].
    Auclerc G; Weil M; Borel C; Khayat D
    Presse Med; 1992 Oct; 21(34):1631-5. PubMed ID: 1470626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
    Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
    Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
    Jakesz R; Hausmaninger H; Haider K; Kubista E; Samonigg H; Gnant M; Manfreda D; Tschurtschenthaler G; Kolb R; Stierer M; Fridrik M; Mlineritsch B; Steindorfer P; Mittlböck M; Steger G
    J Clin Oncol; 1999 Jun; 17(6):1701-9. PubMed ID: 10561206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in breast cancer management.
    Walker BK; Subramanian VP
    W V Med J; 1980 Sep; 76(9):236-41. PubMed ID: 6944964
    [No Abstract]   [Full Text] [Related]  

  • 57. Tamoxifen therapy of metastatic breast cancer.
    Manni A
    J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of menopause during the first year after breast cancer diagnosis.
    Goodwin PJ; Ennis M; Pritchard KI; Trudeau M; Hood N
    J Clin Oncol; 1999 Aug; 17(8):2365-70. PubMed ID: 10561298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic therapy of breast cancer.
    Canellos GP
    Med J Aust; 1988 Jan; 148(2):88-91. PubMed ID: 2447475
    [No Abstract]   [Full Text] [Related]  

  • 60. Systemic therapy in resectable breast cancer.
    Bonadonna G; Valagussa P
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):727-42. PubMed ID: 2691496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.